Haystack MRD test detects minimal residual disease in stage 2 colorectal cancer patients post-surgery, using circulating tumor DNA (ctDNA) for less invasive monitoring. The FDA's breakthrough device ...
The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.
Physical activity, especially walking, significantly reduces fatigue and improves QOL in nonmetastatic colorectal cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results